只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 2026-07-31 2026-07-31 | GRMN GARMIN LTD | MAXFIELD JOSHUA H Officer · VP, General Counsel | 卖出（S） | 272 | US$289.15 | US$78,649.21 | 15,922 | SEC |
| 2026-07-31 2026-07-31 | GRMN GARMIN LTD | MAXFIELD JOSHUA H Officer · VP, General Counsel | 卖出（S） | 438 | US$291.32 | US$127,598.90 | 15,484 | SEC |
| 2026-07-31 2026-07-31 | GRMN GARMIN LTD | MAXFIELD JOSHUA H Officer · VP, General Counsel | 卖出（S） | 442 | US$292.17 | US$129,137.24 | 15,042 | SEC |
| 2026-07-31 2026-07-31 | GRMN GARMIN LTD | Biddlecombe Sean Officer · Managing Director, EMEA | 卖出（S） | 986 | US$292.88 | US$288,779.19 | 6,021 | SEC |
| 2026-07-30 2026-07-31 | IONS IONIS PHARMACEUTICALS INC | Hayden Michael R Director | 买入（P） | 15,000 | US$53.38 | US$800,700.00 | 19,000 | SEC |
| 2026-07-30 2026-07-31 | FMAO FARMERS & MERCHANTS BANCORP INC | Briggs Andrew J Director | 卖出（S） | 3,000 | US$34.86 | US$104,580.00 | 87,550 | SEC |
| 2026-07-30 2026-07-31 | ACAD ACADIA PHARMACEUTICALS INC | Thompson Elizabeth H.Z. Officer · EVP, Head of Research & Dev | 卖出（S） | 16,508 | US$26.13 | US$431,354.04 | 19,044 | SEC |
| 2026-07-30 2026-07-31 | ACAD ACADIA PHARMACEUTICALS INC | Thompson Elizabeth H.Z. Officer · EVP, Head of Research & Dev | 卖出（S） | 50 | US$26.17 | US$1,308.50 | 18,994 | SEC |
| 2026-07-29 2026-07-31 | FMAO FARMERS & MERCHANTS BANCORP INC | Briggs Andrew J Director | 卖出（S） | 3,000 | US$34.48 | US$103,440.00 | 90,550 | SEC |
| 2026-07-29 2026-07-31 | GRMN GARMIN LTD | PEMBLE CLIFTON A Director,Officer · President and CEO | 卖出（S） | 4,029 | US$300.00 | US$120.87万 | 120,127 | SEC |
| 2026-07-29 2026-07-31 | KNSA Kiniksa Pharmaceuticals International, plc | Cole G Bradley Director | 卖出（S） | 3,673 | US$81.43 | US$299,092.39 | 11,672 | SEC |
| 2026-07-29 2026-07-30 | ANIP ANI PHARMACEUTICALS INC | CAREY STEPHEN P. Officer · SVP & CFO | 卖出（S） | 2,850 | US$81.36 | US$231,876.00 | 174,693 | SEC |
| 2026-07-28 2026-07-30 | KPTI Karyopharm Therapeutics Inc. | Poulton Stuart Officer · EVP, Chief Development Officer | 卖出（S） | 189 | US$7.10 | US$1,341.90 | 94,632 | SEC |
| 2026-07-28 2026-07-29 | FMAO FARMERS & MERCHANTS BANCORP INC | Briggs Andrew J Director | 卖出（S） | 3,000 | US$31.59 | US$94,770.00 | 93,550 | SEC |
| 2026-07-27 2026-07-29 | FMAO FARMERS & MERCHANTS BANCORP INC | Briggs Andrew J Director | 卖出（S） | 3,000 | US$30.98 | US$92,940.00 | 96,550 | SEC |
| 2026-07-27 2026-07-29 | NYSE: VTEX VTEX | do Carmo Thomaz Junior Geraldo Officer · Chief Executive Officer | 卖出（S） | 4,808 | US$4.01 | US$19,280.08 | 1,247,303 | SEC |
| 2026-07-24 2026-07-28 | SEIC SEI INVESTMENTS CO | Sharma Sanjay Officer · See Remarks* | 卖出（S） | 20,000 | US$99.33 | US$198.66万 | 39,828.992 | SEC |
| 2026-07-24 2026-07-28 | ORIC Oric Pharmaceuticals, Inc. | Heyman Richard A. Director | 卖出（S） | 7,000 | US$12.02 | US$84,140.00 | 38,300 | SEC |
| 2026-07-24 2026-07-28 | ORIC Oric Pharmaceuticals, Inc. | Heyman Richard A. Director | 卖出（S） | 6,100 | US$12.02 | US$73,322.00 | 206,672 | SEC |
| 2026-07-24 2026-07-27 | OLMA Olema Pharmaceuticals, Inc. | Harmon Cyrus Director | 卖出（S） | 12,500 | US$11.71 | US$146,425.00 | 702,770 | SEC |
| 2026-07-24 2026-07-24 | FMAO FARMERS & MERCHANTS BANCORP INC | Briggs Andrew J Director | 卖出（S） | 3,000 | US$30.44 | US$91,320.00 | 99,550 | SEC |
| 2026-07-23 2026-07-27 | OLMA Olema Pharmaceuticals, Inc. | Harmon Cyrus Director | 卖出（S） | 12,500 | US$11.58 | US$144,737.50 | 715,270 | SEC |
| 2026-07-23 2026-07-24 | FMAO FARMERS & MERCHANTS BANCORP INC | Briggs Andrew J Director | 卖出（S） | 3,000 | US$29.95 | US$89,850.00 | 102,550 | SEC |
| 2026-07-23 2026-07-24 | LEVI LEVI STRAUSS & CO | Singh Harmit J Officer · EVP & Chief Fin. & Growth Ofc. | 卖出（S） | 98,144 | US$24.22 | US$237.7万 | 98,747 | SEC |
| 2026-07-22 2026-07-24 | BMR Beamr Imaging Ltd. | Carmel Sharon Director,Officer,TenPercentOwner · Chief Executive Officer | 买入（P） | 82,650 | US$1.29 | US$106,205.25 | 3,650,840 | SEC |
| 2026-07-22 2026-07-22 | FMAO FARMERS & MERCHANTS BANCORP INC | Briggs Andrew J Director | 卖出（S） | 3,000 | US$30.84 | US$92,520.00 | 105,550 | SEC |
| 2026-07-21 2026-07-22 | FMAO FARMERS & MERCHANTS BANCORP INC | Briggs Andrew J Director | 卖出（S） | 3,000 | US$30.75 | US$92,250.00 | 108,550 | SEC |
| 2026-07-21 2026-07-22 | PLMR Palomar Holdings, Inc. | Armstrong Mac Director,Officer · CEO and Chairman | 卖出（S） | 2,103 | US$136.70 | US$287,476.52 | 327,285 | SEC |
| 2026-07-21 2026-07-22 | PLMR Palomar Holdings, Inc. | Armstrong Mac Director,Officer · CEO and Chairman | 卖出（S） | 937 | US$137.74 | US$129,060.69 | 326,348 | SEC |
| 2026-07-21 2026-07-22 | PLMR Palomar Holdings, Inc. | Armstrong Mac Director,Officer · CEO and Chairman | 卖出（S） | 260 | US$138.47 | US$36,001.11 | 326,088 | SEC |
| 2026-07-21 2026-07-22 | PLMR Palomar Holdings, Inc. | Armstrong Mac Director,Officer · CEO and Chairman | 卖出（S） | 200 | US$139.43 | US$27,886.00 | 325,888 | SEC |
| 2026-07-20 2026-07-22 | NAMS NewAmsterdam Pharma Co N.V. | Kooij Louise Frederika Officer · Chief Accounting Officer | 卖出（S） | 70,200 | US$29.96 | US$210.32万 | 59,153 | SEC |
| 2026-07-20 2026-07-22 | NAMS NewAmsterdam Pharma Co N.V. | Kooij Louise Frederika Officer · Chief Accounting Officer | 卖出（S） | 31,885 | US$31.05 | US$990,029.25 | 27,268 | SEC |
| 2026-07-20 2026-07-22 | NAMS NewAmsterdam Pharma Co N.V. | Kooij Louise Frederika Officer · Chief Accounting Officer | 卖出（S） | 2,915 | US$31.71 | US$92,434.65 | 24,353 | SEC |
| 2026-07-20 2026-07-22 | FMAO FARMERS & MERCHANTS BANCORP INC | Briggs Andrew J Director | 卖出（S） | 3,000 | US$30.47 | US$91,410.00 | 111,550 | SEC |
| 2026-07-20 2026-07-21 | NYSE: VTEX VTEX | do Carmo Thomaz Junior Geraldo Officer · Chief Executive Officer | 卖出（S） | 4,808 | US$4.22 | US$20,289.76 | 1,252,111 | SEC |
| 2026-07-20 2026-07-20 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sibold William John Director,Officer · President and CEO | 卖出（S） | 140 | US$542.75 | US$75,984.43 | 211,689 | SEC |
| 2026-07-20 2026-07-20 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sibold William John Director,Officer · President and CEO | 卖出（S） | 280 | US$555.05 | US$155,414.00 | 209,329 | SEC |
| 2026-07-20 2026-07-20 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sibold William John Director,Officer · President and CEO | 卖出（S） | 110 | US$543.79 | US$59,817.22 | 211,579 | SEC |
| 2026-07-20 2026-07-20 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sibold William John Director,Officer · President and CEO | 卖出（S） | 545 | US$544.71 | US$296,869.13 | 211,034 | SEC |
| 2026-07-20 2026-07-20 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sibold William John Director,Officer · President and CEO | 卖出（S） | 275 | US$545.71 | US$150,070.03 | 210,759 | SEC |
| 2026-07-20 2026-07-20 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sibold William John Director,Officer · President and CEO | 卖出（S） | 269 | US$547.08 | US$147,164.20 | 210,490 | SEC |
| 2026-07-20 2026-07-20 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sibold William John Director,Officer · President and CEO | 卖出（S） | 680 | US$547.70 | US$372,434.64 | 209,810 | SEC |
| 2026-07-20 2026-07-20 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sibold William John Director,Officer · President and CEO | 卖出（S） | 47 | US$548.87 | US$25,796.98 | 209,763 | SEC |
| 2026-07-20 2026-07-20 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sibold William John Director,Officer · President and CEO | 卖出（S） | 153 | US$550.01 | US$84,152.11 | 209,610 | SEC |
| 2026-07-20 2026-07-20 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sibold William John Director,Officer · President and CEO | 卖出（S） | 1 | US$550.72 | US$550.72 | 209,609 | SEC |
| 2026-07-17 2026-07-20 | LYEL Lyell Immunopharma, Inc. | Innovative Cellular Therapeutics Holdings Ltd TenPercentOwner | 卖出（S） | 10 | US$13.70 | US$137.00 | 2,857,480 | SEC |
| 2026-07-17 2026-07-17 | FMAO FARMERS & MERCHANTS BANCORP INC | Briggs Andrew J Director | 卖出（S） | 3,000 | US$31.06 | US$93,180.00 | 114,550 | SEC |
| 2026-07-16 2026-07-21 | VOR Vor Biopharma Inc. | RA CAPITAL MANAGEMENT, L.P. TenPercentOwner | 卖出（S） | 213 | US$19.75 | US$4,206.75 | 4,501,882 | SEC |
| 2026-07-16 2026-07-21 | VOR Vor Biopharma Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 卖出（S） | 213 | US$19.75 | US$4,206.75 | 4,501,882 | SEC |
| 2026-07-16 2026-07-21 | VOR Vor Biopharma Inc. | Kolchinsky Peter TenPercentOwner | 卖出（S） | 213 | US$19.75 | US$4,206.75 | 4,501,882 | SEC |
| 2026-07-16 2026-07-21 | VOR Vor Biopharma Inc. | Shah Rajeev M. TenPercentOwner | 卖出（S） | 213 | US$19.75 | US$4,206.75 | 4,501,882 | SEC |
| 2026-07-16 2026-07-20 | CBIO CRESCENT BIOPHARMA, INC. | Fairmount Funds Management LLC Director,TenPercentOwner | 买入（P） | 853,450 | US$14.50 | US$1237.5万 | 3,601,316 | SEC |
| 2026-07-16 2026-07-20 | CBIO CRESCENT BIOPHARMA, INC. | Fairmount Healthcare Fund II L.P. Director,TenPercentOwner | 买入（P） | 853,450 | US$14.50 | US$1237.5万 | 3,601,316 | SEC |
| 2026-07-16 2026-07-20 | CBIO CRESCENT BIOPHARMA, INC. | Kiselak Tomas Director,TenPercentOwner | 买入（P） | 853,450 | US$14.50 | US$1237.5万 | 3,601,316 | SEC |
| 2026-07-16 2026-07-20 | CBIO CRESCENT BIOPHARMA, INC. | Harwin Peter Evan Director,TenPercentOwner | 买入（P） | 853,450 | US$14.50 | US$1237.5万 | 3,601,316 | SEC |
| 2026-07-16 2026-07-17 | LYEL Lyell Immunopharma, Inc. | Innovative Cellular Therapeutics Holdings Ltd TenPercentOwner | 卖出（S） | 10 | US$13.73 | US$137.30 | 2,857,490 | SEC |
| 2026-07-16 2026-07-17 | GLUE Monte Rosa Therapeutics, Inc. | Warmuth Markus Director,Officer · President & CEO | 卖出（S） | 9,500 | US$23.18 | US$220,218.55 | 585,038 | SEC |
| 2026-07-16 2026-07-17 | FMAO FARMERS & MERCHANTS BANCORP INC | Briggs Andrew J Director | 卖出（S） | 3,000 | US$30.06 | US$90,180.00 | 117,550 | SEC |
| 2026-07-16 2026-07-17 | RELY Remitly Global, Inc. | Sharma Pankaj Officer · Chief Business Officer | 卖出（S） | 15,000 | US$25.03 | US$375,450.00 | 752,810 | SEC |
| 2026-07-16 2026-07-16 | ADIL ADIAL PHARMACEUTICALS, INC. | Coastlands Capital LP TenPercentOwner | 买入（P） | 1,233 | US$2.75 | US$3,390.75 | 388,308 | SEC |
| 2026-07-16 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 19 | US$1.55 | US$29.45 | 743,057 | SEC |
| 2026-07-16 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 19 | US$1.55 | US$29.45 | 743,057 | SEC |
| 2026-07-16 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 19 | US$1.55 | US$29.45 | 743,057 | SEC |
| 2026-07-16 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 19 | US$1.55 | US$29.45 | 743,057 | SEC |
| 2026-07-16 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 2 | US$1.55 | US$3.10 | 75,019 | SEC |
| 2026-07-16 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 2 | US$1.55 | US$3.10 | 75,019 | SEC |
| 2026-07-16 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 2 | US$1.55 | US$3.10 | 75,019 | SEC |
| 2026-07-16 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 2 | US$1.55 | US$3.10 | 75,019 | SEC |
| 2026-07-15 2026-07-17 | PLMR Palomar Holdings, Inc. | Armstrong Mac Director,Officer · CEO and Chairman | 卖出（S） | 3,197 | US$131.66 | US$420,917.02 | 105,112 | SEC |
| 2026-07-15 2026-07-17 | PLMR Palomar Holdings, Inc. | Armstrong Mac Director,Officer · CEO and Chairman | 卖出（S） | 57,544 | US$131.66 | US$757.62万 | 160,068 | SEC |
| 2026-07-15 2026-07-17 | INM InMed Pharmaceuticals Inc. | ADAR1 Capital Management, LLC TenPercentOwner | 买入（P） | 1,000 | US$1.56 | US$1,555.00 | 801,000 | SEC |
| 2026-07-15 2026-07-17 | INM InMed Pharmaceuticals Inc. | Schneeberger Daniel TenPercentOwner | 买入（P） | 1,000 | US$1.56 | US$1,555.00 | 801,000 | SEC |
| 2026-07-15 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 13,761 | US$1.55 | US$21,329.55 | 743,038 | SEC |
| 2026-07-15 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 13,761 | US$1.55 | US$21,329.55 | 743,038 | SEC |
| 2026-07-15 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 13,761 | US$1.55 | US$21,329.55 | 743,038 | SEC |
| 2026-07-15 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 13,761 | US$1.55 | US$21,329.55 | 743,038 | SEC |
| 2026-07-15 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 1,389 | US$1.55 | US$2,152.95 | 75,017 | SEC |
| 2026-07-15 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 1,389 | US$1.55 | US$2,152.95 | 75,017 | SEC |
| 2026-07-15 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 1,389 | US$1.55 | US$2,152.95 | 75,017 | SEC |
| 2026-07-15 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 1,389 | US$1.55 | US$2,152.95 | 75,017 | SEC |
| 2026-07-15 2026-07-16 | CSW CSW INDUSTRIALS, INC. | Armes Joseph B Director,Officer · Chairman, President & CEO | 卖出（S） | 1,500 | US$289.95 | US$434,920.80 | 67,600 | SEC |
| 2026-07-15 2026-07-15 | FMAO FARMERS & MERCHANTS BANCORP INC | Briggs Andrew J Director | 卖出（S） | 3,000 | US$29.81 | US$89,430.00 | 120,550 | SEC |
| 2026-07-14 2026-07-16 | ADIL ADIAL PHARMACEUTICALS, INC. | Coastlands Capital LP TenPercentOwner | 买入（P） | 2,000 | US$2.65 | US$5,300.00 | 387,075 | SEC |
| 2026-07-14 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 4,882 | US$1.55 | US$7,567.10 | 729,277 | SEC |
| 2026-07-14 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 4,882 | US$1.55 | US$7,567.10 | 729,277 | SEC |
| 2026-07-14 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 4,882 | US$1.55 | US$7,567.10 | 729,277 | SEC |
| 2026-07-14 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 4,882 | US$1.55 | US$7,567.10 | 729,277 | SEC |
| 2026-07-14 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 493 | US$1.55 | US$764.15 | 73,628 | SEC |
| 2026-07-14 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 493 | US$1.55 | US$764.15 | 73,628 | SEC |
| 2026-07-14 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 493 | US$1.55 | US$764.15 | 73,628 | SEC |
| 2026-07-14 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 493 | US$1.55 | US$764.15 | 73,628 | SEC |
| 2026-07-14 2026-07-16 | ETON Eton Pharmaceuticals, Inc. | Opaleye Management Inc. TenPercentOwner | 卖出（S） | 15,000 | US$37.54 | US$563,146.50 | 2,665,000 | SEC |
| 2026-07-14 2026-07-16 | ETON Eton Pharmaceuticals, Inc. | Opaleye Management Inc. TenPercentOwner | 卖出（S） | 13,315 | US$37.54 | US$499,886.38 | 40,000 | SEC |
| 2026-07-14 2026-07-15 | FMAO FARMERS & MERCHANTS BANCORP INC | Briggs Andrew J Director | 卖出（S） | 3,000 | US$30.10 | US$90,300.00 | 123,550 | SEC |
| 2026-07-14 2026-07-15 | SHPH Shuttle Pharmaceuticals Holdings, Inc. | HRT FINANCIAL LP TenPercentOwner | 卖出（S） | 82,116 | US$4.48 | US$367,879.68 | 0 | SEC |
| 2026-07-13 2026-07-15 | NYSE: VTEX VTEX | do Carmo Thomaz Junior Geraldo Officer · Chief Executive Officer | 卖出（S） | 4,808 | US$4.09 | US$19,664.72 | 1,256,919 | SEC |
| 2026-07-13 2026-07-15 | FMAO FARMERS & MERCHANTS BANCORP INC | Briggs Andrew J Director | 卖出（S） | 3,000 | US$29.77 | US$89,310.00 | 126,550 | SEC |
| 2026-07-13 2026-07-15 | SHPH Shuttle Pharmaceuticals Holdings, Inc. | HRT FINANCIAL LP TenPercentOwner | 卖出（S） | 1,033 | US$4.67 | US$4,824.11 | 60,238 | SEC |
| 2026-07-13 2026-07-14 | ANIP ANI PHARMACEUTICALS INC | Cook Meredith Officer · SR. VP, GENERAL COUNSEL & SEC. | 卖出（S） | 500 | US$81.84 | US$40,920.00 | 77,390 | SEC |
| 2026-07-10 2026-07-13 | ADIL ADIAL PHARMACEUTICALS, INC. | Coastlands Capital LP TenPercentOwner | 买入（P） | 1,700 | US$2.70 | US$4,590.00 | 385,075 | SEC |
| 2026-07-10 2026-07-13 | RDHL RedHill Biopharma Ltd. | Raday Gilead Officer · Chief Operating Officer | 卖出（S） | 14,130,000 | US$0.00 | US$1,413.00 | 218,780,000 | SEC |
| 2026-07-10 2026-07-13 | AMLX Amylyx Pharmaceuticals, Inc. | Mazzariello Gina Officer · Chief Legal Officer | 卖出（S） | 15,000 | US$17.61 | US$264,121.50 | 179,090 | SEC |
| 2026-07-10 2026-07-13 | SHPH Shuttle Pharmaceuticals Holdings, Inc. | HRT FINANCIAL LP TenPercentOwner | 买入（P） | 731 | US$3.11 | US$2,273.41 | 61,271 | SEC |
| 2026-07-10 2026-07-13 | INDV Indivior Pharmaceuticals, Inc. | Heidbreder Christian Officer · Chief Scientific Officer | 卖出（S） | 18,586 | US$41.14 | US$764,628.04 | 209,337 | SEC |
| 2026-07-10 2026-07-10 | FMAO FARMERS & MERCHANTS BANCORP INC | Briggs Andrew J Director | 卖出（S） | 3,000 | US$29.52 | US$88,560.00 | 129,550 | SEC |
| 2026-07-09 2026-07-13 | ADIL ADIAL PHARMACEUTICALS, INC. | Coastlands Capital LP TenPercentOwner | 买入（P） | 10,053 | US$2.79 | US$28,047.87 | 383,375 | SEC |
| 2026-07-09 2026-07-13 | AMLX Amylyx Pharmaceuticals, Inc. | Mazzariello Gina Officer · Chief Legal Officer | 卖出（S） | 15,000 | US$18.32 | US$274,746.00 | 194,090 | SEC |
| 2026-07-09 2026-07-13 | BBIO BridgeBio Pharma, Inc. | Cook Jennifer E. Director | 卖出（S） | 36,167 | US$84.00 | US$303.8万 | 120,805 | SEC |
| 2026-07-09 2026-07-13 | BBIO BridgeBio Pharma, Inc. | Cook Jennifer E. Director | 卖出（S） | 112,422 | US$90.00 | US$1011.8万 | 8,383 | SEC |
| 2026-07-09 2026-07-13 | BBIO BridgeBio Pharma, Inc. | Ellis Andrea Director | 卖出（S） | 17,167 | US$84.00 | US$144.2万 | 22,579 | SEC |
| 2026-07-09 2026-07-13 | SHPH Shuttle Pharmaceuticals Holdings, Inc. | HRT FINANCIAL LP TenPercentOwner | 买入（P） | 8,266 | US$3.38 | US$27,939.08 | 60,540 | SEC |
| 2026-07-09 2026-07-10 | BB BLACKBERRY Ltd | Armstrong-Owen Jennifer Officer · Sr VP & Chief People Officer | 卖出（S） | 3,296 | US$10.92 | US$35,992.32 | 106,091 | SEC |
| 2026-07-09 2026-07-10 | FMAO FARMERS & MERCHANTS BANCORP INC | Briggs Andrew J Director | 卖出（S） | 3,000 | US$29.42 | US$88,260.00 | 132,550 | SEC |
| 2026-07-09 2026-07-10 | URGN UroGen Pharma Ltd. | Schoenberg Mark Officer · Chief Medical Officer | 卖出（S） | 10,000 | US$40.00 | US$400,000.00 | 119,763 | SEC |
| 2026-07-08 2026-07-09 | SNDX Syndax Pharmaceuticals Inc | Metzger Michael A Director,Officer · Chief Executive Officer | 卖出（S） | 32,375 | US$24.24 | US$784,776.48 | 484,843 | SEC |
| 2026-07-08 2026-07-09 | SHPH Shuttle Pharmaceuticals Holdings, Inc. | HRT FINANCIAL LP TenPercentOwner | 卖出（S） | 18,531 | US$3.52 | US$65,229.12 | 52,274 | SEC |
| 2026-07-08 2026-07-08 | FMAO FARMERS & MERCHANTS BANCORP INC | Briggs Andrew J Director | 卖出（S） | 3,000 | US$30.15 | US$90,450.00 | 135,550 | SEC |
| 2026-07-08 2026-07-08 | CTNM Contineum Therapeutics, Inc. | Stengone Carmine N. Director,Officer · CEO and President | 卖出（S） | 2,500 | US$16.00 | US$40,000.00 | 17,217 | SEC |
| 2026-07-07 2026-07-09 | IONS IONIS PHARMACEUTICALS INC | Kordasiewicz Holly B. Officer · EVP, Chief Development Officer | 卖出（S） | 362 | US$84.30 | US$30,516.60 | 22,096 | SEC |
| 2026-07-07 2026-07-09 | IONS IONIS PHARMACEUTICALS INC | Diaz Allene M. Director | 卖出（S） | 10,111 | US$85.42 | US$863,637.13 | 3,811 | SEC |
| 2026-07-07 2026-07-09 | IONS IONIS PHARMACEUTICALS INC | BENNETT C FRANK Officer · EVP, Chief Scientific Officer | 卖出（S） | 5,536 | US$83.58 | US$462,693.34 | 75,018 | SEC |
| 2026-07-07 2026-07-09 | IONS IONIS PHARMACEUTICALS INC | BENNETT C FRANK Officer · EVP, Chief Scientific Officer | 卖出（S） | 15,000 | US$85.46 | US$128.19万 | 0 | SEC |
| 2026-07-07 2026-07-09 | IRWD IRONWOOD PHARMACEUTICALS INC | Silver Ronald Officer · PFO & PAO | 卖出（S） | 127,890 | US$4.52 | US$578,062.80 | 313,680 | SEC |
| 2026-07-07 2026-07-09 | SHPH Shuttle Pharmaceuticals Holdings, Inc. | HRT FINANCIAL LP TenPercentOwner | 卖出（S） | 10,580 | US$3.33 | US$35,231.40 | 70,805 | SEC |
| 2026-07-07 2026-07-09 | RXRX RECURSION PHARMACEUTICALS, INC. | Borgeson Blake Director | 卖出（S） | 40,000 | US$3.96 | US$158,500.00 | 6,218,287 | SEC |
| 2026-07-07 2026-07-08 | FMAO FARMERS & MERCHANTS BANCORP INC | Briggs Andrew J Director | 卖出（S） | 3,000 | US$30.72 | US$92,160.00 | 138,550 | SEC |
| 2026-07-07 2026-07-08 | SFM Sprouts Farmers Market, Inc. | Sinclair Jack Director,Officer · Chief Executive Officer | 卖出（S） | 10,788 | US$84.87 | US$915,594.82 | 269,980 | SEC |
| 2026-07-07 2026-07-08 | TBPH Theravance Biopharma, Inc. | Samaha Eli TenPercentOwner | 卖出（S） | 5,564 | US$17.17 | US$95,540.56 | 9,167,489 | SEC |
| 2026-07-07 2026-07-07 | ETON Eton Pharmaceuticals, Inc. | Opaleye Management Inc. TenPercentOwner | 卖出（S） | 20,000 | US$38.37 | US$767,456.00 | 2,680,000 | SEC |
| 2026-07-07 2026-07-07 | ETON Eton Pharmaceuticals, Inc. | Opaleye Management Inc. TenPercentOwner | 卖出（S） | 6,685 | US$38.37 | US$256,522.17 | 53,315 | SEC |
| 2026-07-07 2026-07-07 | XERS Xeris Biopharma Holdings, Inc. | Pieper Steven Officer · See Remarks | 卖出（S） | 27,600 | US$8.52 | US$235,276.20 | 1,366,053 | SEC |
| 2026-07-06 2026-07-08 | NYSE: VTEX VTEX | do Carmo Thomaz Junior Geraldo Officer · Chief Executive Officer | 卖出（S） | 4,808 | US$4.06 | US$19,520.48 | 1,261,727 | SEC |
| 2026-07-06 2026-07-08 | MIRM Mirum Pharmaceuticals, Inc. | BJERKHOLT ERIC Officer · CHIEF FINANCIAL OFFICER | 卖出（S） | 3,124 | US$121.67 | US$380,097.08 | 44,057 | SEC |
| 2026-07-06 2026-07-08 | MIRM Mirum Pharmaceuticals, Inc. | BJERKHOLT ERIC Officer · CHIEF FINANCIAL OFFICER | 卖出（S） | 1,048 | US$122.43 | US$128,306.64 | 43,009 | SEC |
| 2026-07-06 2026-07-08 | MIRM Mirum Pharmaceuticals, Inc. | BJERKHOLT ERIC Officer · CHIEF FINANCIAL OFFICER | 卖出（S） | 528 | US$123.84 | US$65,387.52 | 42,481 | SEC |
| 2026-07-06 2026-07-08 | MIRM Mirum Pharmaceuticals, Inc. | BJERKHOLT ERIC Officer · CHIEF FINANCIAL OFFICER | 卖出（S） | 300 | US$124.94 | US$37,482.00 | 42,181 | SEC |
| 2026-07-06 2026-07-08 | ORIC Oric Pharmaceuticals, Inc. | Heyman Richard A. Director | 卖出（S） | 300 | US$12.00 | US$3,600.00 | 212,772 | SEC |
| 2026-07-06 2026-07-08 | MIRM Mirum Pharmaceuticals, Inc. | Peetz Christopher Director,Officer · CHIEF EXECUTIVE OFFICER | 卖出（S） | 12,134 | US$121.65 | US$147.61万 | 202,175 | SEC |
| 2026-07-06 2026-07-08 | MIRM Mirum Pharmaceuticals, Inc. | Peetz Christopher Director,Officer · CHIEF EXECUTIVE OFFICER | 卖出（S） | 4,181 | US$122.34 | US$511,503.54 | 197,994 | SEC |
| 2026-07-06 2026-07-08 | MIRM Mirum Pharmaceuticals, Inc. | Peetz Christopher Director,Officer · CHIEF EXECUTIVE OFFICER | 卖出（S） | 1,975 | US$123.74 | US$244,386.50 | 196,019 | SEC |
| 2026-07-06 2026-07-08 | MIRM Mirum Pharmaceuticals, Inc. | Peetz Christopher Director,Officer · CHIEF EXECUTIVE OFFICER | 卖出（S） | 1,710 | US$124.79 | US$213,390.90 | 194,309 | SEC |
| 2026-07-06 2026-07-08 | SFM Sprouts Farmers Market, Inc. | Sinclair Jack Director,Officer · Chief Executive Officer | 卖出（S） | 10,788 | US$87.41 | US$942,963.98 | 269,980 | SEC |
| 2026-07-06 2026-07-08 | TBPH Theravance Biopharma, Inc. | Samaha Eli TenPercentOwner | 卖出（S） | 1,400 | US$17.04 | US$23,856.00 | 9,173,053 | SEC |
| 2026-07-06 2026-07-07 | SHPH Shuttle Pharmaceuticals Holdings, Inc. | HRT FINANCIAL LP TenPercentOwner | 卖出（S） | 9,022 | US$3.51 | US$31,667.22 | 81,385 | SEC |
| 2026-07-06 2026-07-07 | ETON Eton Pharmaceuticals, Inc. | Opaleye Management Inc. TenPercentOwner | 卖出（S） | 10,000 | US$38.00 | US$380,000.00 | 2,700,000 | SEC |
| 2026-07-06 2026-07-07 | XERS Xeris Biopharma Holdings, Inc. | Pieper Steven Officer · See Remarks | 卖出（S） | 17,400 | US$8.50 | US$147,900.00 | 1,393,653 | SEC |
| 2026-07-06 2026-07-06 | FMAO FARMERS & MERCHANTS BANCORP INC | Briggs Andrew J Director | 卖出（S） | 3,000 | US$30.67 | US$92,010.00 | 141,550 | SEC |
| 2026-07-02 2026-07-07 | VRTX VERTEX PHARMACEUTICALS INC / MA | McKechnie Duncan Officer · EVP, Chief Commercial Officer | 卖出（S） | 1,541 | US$519.00 | US$799,779.00 | 11,001 | SEC |
| 2026-07-02 2026-07-07 | VRTX VERTEX PHARMACEUTICALS INC / MA | Tatsis Ourania Officer · EVP, Chief Reg. & Quality Off. | 卖出（S） | 1,500 | US$524.99 | US$787,485.00 | 45,321 | SEC |
| 2026-07-02 2026-07-07 | REGN REGENERON PHARMACEUTICALS, INC. | RYAN ARTHUR F Director | 卖出（S） | 200 | US$650.15 | US$130,030.00 | 17,303 | SEC |
| 2026-07-02 2026-07-07 | SHPH Shuttle Pharmaceuticals Holdings, Inc. | HRT FINANCIAL LP TenPercentOwner | 买入（P） | 7,851 | US$3.54 | US$27,792.54 | 90,407 | SEC |
| 2026-07-02 2026-07-07 | ETON Eton Pharmaceuticals, Inc. | Opaleye Management Inc. TenPercentOwner | 卖出（S） | 65,000 | US$37.39 | US$243万 | 2,710,000 | SEC |
| 2026-07-02 2026-07-07 | ETON Eton Pharmaceuticals, Inc. | Opaleye Management Inc. TenPercentOwner | 卖出（S） | 25,000 | US$37.39 | US$934,627.50 | 60,000 | SEC |
| 2026-07-02 2026-07-07 | CRNX Crinetics Pharmaceuticals, Inc. | Vivaldi Coelho Rogerio Director | 卖出（S） | 3,000 | US$40.00 | US$120,000.00 | 19,225 | SEC |
| 2026-07-02 2026-07-06 | BB BLACKBERRY Ltd | Armstrong-Owen Jennifer Officer · Sr VP & Chief People Officer | 卖出（S） | 2,556 | US$11.22 | US$28,678.32 | 101,751 | SEC |
| 2026-07-02 2026-07-06 | FMAO FARMERS & MERCHANTS BANCORP INC | Briggs Andrew J Director | 卖出（S） | 3,000 | US$31.53 | US$94,590.00 | 144,550 | SEC |
| 2026-07-02 2026-07-06 | ANIP ANI PHARMACEUTICALS INC | CAREY STEPHEN P. Officer · SVP & CFO | 卖出（S） | 3,313 | US$86.00 | US$284,918.00 | 177,543 | SEC |
| 2026-07-02 2026-07-06 | YELP YELP INC | Amara Carmen Officer · Chief People Officer | 卖出（S） | 23,233 | US$27.00 | US$627,291.00 | 105,991 | SEC |
| 2026-07-02 2026-07-02 | ALRM Alarm.com Holdings, Inc. | Bradley Kevin Christopher Officer · Chief Financial Officer | 卖出（S） | 724 | US$48.46 | US$35,085.04 | 83,622 | SEC |
| 2026-07-02 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 1,460 | US$1.55 | US$2,263.00 | 724,395 | SEC |
| 2026-07-02 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 1,460 | US$1.55 | US$2,263.00 | 724,395 | SEC |
| 2026-07-02 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 1,460 | US$1.55 | US$2,263.00 | 724,395 | SEC |
| 2026-07-02 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 1,460 | US$1.55 | US$2,263.00 | 724,395 | SEC |
| 2026-07-02 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 147 | US$1.55 | US$227.85 | 73,135 | SEC |
| 2026-07-02 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 147 | US$1.55 | US$227.85 | 73,135 | SEC |
| 2026-07-02 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 147 | US$1.55 | US$227.85 | 73,135 | SEC |
| 2026-07-02 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 147 | US$1.55 | US$227.85 | 73,135 | SEC |
| 2026-07-01 2026-07-06 | IONS IONIS PHARMACEUTICALS INC | KLEIN JOSEPH III Director | 卖出（S） | 99 | US$79.45 | US$7,865.55 | 22,433 | SEC |
| 2026-07-01 2026-07-06 | IONS IONIS PHARMACEUTICALS INC | KLEIN JOSEPH III Director | 卖出（S） | 11,419 | US$79.04 | US$902,550.91 | 11,014 | SEC |
| 2026-07-01 2026-07-06 | VRTX VERTEX PHARMACEUTICALS INC / MA | Liu Joy Officer · EVP and Chief Legal Officer | 卖出（S） | 828 | US$502.71 | US$416,243.88 | 19,131 | SEC |
| 2026-07-01 2026-07-06 | RARE Ultragenyx Pharmaceutical Inc. | Horn Howard Officer · Chief Financial Officer | 卖出（S） | 4,698 | US$33.13 | US$155,644.74 | 100,991 | SEC |
| 2026-07-01 2026-07-06 | JAZZ Jazz Pharmaceuticals plc | COZADD BRUCE C Director | 卖出（S） | 6,000 | US$240.47 | US$144.28万 | 366,682 | SEC |
| 2026-07-01 2026-07-06 | YELP YELP INC | Amara Carmen Officer · Chief People Officer | 卖出（S） | 1,500 | US$24.95 | US$37,425.00 | 129,224 | SEC |
| 2026-07-01 2026-07-06 | LGND LIGAND PHARMACEUTICALS INC | Reardon Andrew Officer · CLO & Secretary | 卖出（S） | 396 | US$308.99 | US$122,359.49 | 46,118 | SEC |
| 2026-07-01 2026-07-06 | LGND LIGAND PHARMACEUTICALS INC | Reardon Andrew Officer · CLO & Secretary | 卖出（S） | 104 | US$310.20 | US$32,261.04 | 46,014 | SEC |
| 2026-07-01 2026-07-06 | LGND LIGAND PHARMACEUTICALS INC | Reardon Andrew Officer · CLO & Secretary | 卖出（S） | 1,119 | US$311.72 | US$348,814.68 | 44,895 | SEC |
| 2026-07-01 2026-07-06 | LGND LIGAND PHARMACEUTICALS INC | Reardon Andrew Officer · CLO & Secretary | 卖出（S） | 1,081 | US$312.28 | US$337,572.95 | 43,814 | SEC |
| 2026-07-01 2026-07-06 | LGND LIGAND PHARMACEUTICALS INC | Reardon Andrew Officer · CLO & Secretary | 卖出（S） | 700 | US$313.46 | US$219,420.18 | 43,114 | SEC |
| 2026-07-01 2026-07-06 | LGND LIGAND PHARMACEUTICALS INC | Reardon Andrew Officer · CLO & Secretary | 卖出（S） | 100 | US$314.58 | US$31,457.88 | 43,014 | SEC |
| 2026-07-01 2026-07-06 | LGND LIGAND PHARMACEUTICALS INC | Reardon Andrew Officer · CLO & Secretary | 卖出（S） | 900 | US$315.78 | US$284,199.75 | 42,114 | SEC |
| 2026-07-01 2026-07-06 | LGND LIGAND PHARMACEUTICALS INC | Reardon Andrew Officer · CLO & Secretary | 卖出（S） | 600 | US$317.15 | US$190,291.02 | 41,514 | SEC |
| 2026-07-01 2026-07-06 | BZAI Blaize Holdings, Inc. | Sehmi Harminder Officer · Chief Financial Officer | 卖出（S） | 40,609 | US$1.37 | US$55,634.33 | 259,773 | SEC |
| 2026-07-01 2026-07-02 | ORMP ORAMED PHARMACEUTICALS INC. | Gabay Avraham Officer · Chief Financial Officer | 卖出（S） | 73,360 | US$4.51 | US$330,743.56 | 671,785 | SEC |
| 2026-07-01 2026-07-02 | ORMP ORAMED PHARMACEUTICALS INC. | Hexter Joshua Officer · COO & CBO | 卖出（S） | 137,000 | US$4.46 | US$611,431.00 | 1,023,384 | SEC |
| 2026-07-01 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 3,946 | US$1.55 | US$6,116.30 | 722,935 | SEC |
| 2026-07-01 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 3,946 | US$1.55 | US$6,116.30 | 722,935 | SEC |
| 2026-07-01 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 3,946 | US$1.55 | US$6,116.30 | 722,935 | SEC |
| 2026-07-01 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 3,946 | US$1.55 | US$6,116.30 | 722,935 | SEC |
| 2026-07-01 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 398 | US$1.55 | US$616.90 | 72,988 | SEC |
| 2026-07-01 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 398 | US$1.55 | US$616.90 | 72,988 | SEC |
| 2026-07-01 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 398 | US$1.55 | US$616.90 | 72,988 | SEC |
| 2026-07-01 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 398 | US$1.55 | US$616.90 | 72,988 | SEC |
| 2026-07-01 2026-07-02 | AGIO AGIOS PHARMACEUTICALS, INC. | Gheuens Sarah Officer · Chief Medical Officer | 卖出（S） | 4,007 | US$37.56 | US$150,502.92 | 84,645 | SEC |
| 2026-07-01 2026-07-02 | FENC FENNEC PHARMACEUTICALS INC. | Raykov Rosty Other | 卖出（S） | 9,599 | US$10.41 | US$99,925.59 | 138,855 | SEC |
| 2026-07-01 2026-07-02 | SHPH Shuttle Pharmaceuticals Holdings, Inc. | HRT FINANCIAL LP TenPercentOwner | 买入（P） | 3,959 | US$3.30 | US$13,064.70 | 82,556 | SEC |
| 2026-07-01 2026-07-02 | XERS Xeris Biopharma Holdings, Inc. | Hecht Beth Officer · See Remarks | 卖出（S） | 16,666 | US$8.03 | US$133,859.65 | 1,161,128 | SEC |
| 2026-07-01 2026-07-02 | RPRX Royalty Pharma plc | Urist Marshall Officer · EVP, Research & Investments | 卖出（S） | 9,099 | US$55.88 | US$508,453.94 | 0 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| ARMP | 8,863.61 | 0 | 10,115.5302 | 87.62% | B, Q, N |
| ARMW | 23,781.1119 | 0 | 33,859.4888 | 70.23% | B, Q, N |
| ARM | 1,699,037.1757 | 2,477 | 2,981,109.9608 | 56.99% | B, Q, N |
| ARMA | 670.2968 | 0 | 1,195.663 | 56.06% | Q |
| ARMS | 1,703.0399 | 0 | 4,907.0399 | 34.71% | Q |
| ARMK | 135,522.0251 | 274 | 475,143.4889 | 28.52% | B, Q, N |
| ARMG | 71,986.7448 | 5,985 | 253,472.4848 | 28.40% | B, Q, N |
| MARM | 4 | 0 | 28.8402 | 13.87% | Q |
| ARMY | 61 | 0 | 3,242.7931 | 1.88% | Q |
| ARMH | 1 | 0 | 10,963.8175 | 0.01% | Q |